Why the study?
Do in vivo and protease-activated receptor-1-mediated platelet activation predict two-year clinical outcomes in patients undergoing angioplasty and stenting for lower extremity artery disease?
Population
108 patients receiving dual antiplatelet therapy after infrainguinal angioplasty and stenting for lower…
Design
Cohort
Follow-up
two-year
Loading...
May aid risk stratification after peripheral stenting; leaves open whether targeting platelet activation improves outcomes.
Do in vivo and protease-activated receptor-1-mediated platelet activation predict two-year clinical outcomes in patients undergoing angioplasty and stenting for lower extremity artery disease?
In vivo and TRAP-6-inducible platelet activation, but not response to standard antiplatelet therapy testing, predict two-year adverse outcomes after peripheral angioplasty and stenting for lower extremity artery disease.
A 2013 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: